Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diphenhydramine mouthwash for pain during inferior alveolar nerve block injection
IRCT20250412065293N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of diphenhydramine in None (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoint: Pain. Started May 2025; status: completed.
02
Drugs
diphenhydramine
Beyond the preview
Go deeper on IRCT20250412065293N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250412065293N1.